TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $180,648 | -12.7% | 11,580 | -21.6% | 0.05% | -43.4% |
| Q2 2022 | $207,000 | +4.5% | 14,772 | +6.7% | 0.08% | +219.2% |
| Q1 2022 | $198,000 | -34.0% | 13,850 | -37.1% | 0.03% | -51.9% |
| Q4 2021 | $300,000 | -85.7% | 22,019 | -82.8% | 0.05% | -73.3% |
| Q3 2021 | $2,095,000 | +52.4% | 127,875 | +56.6% | 0.20% | +4.7% |
| Q2 2021 | $1,375,000 | +329.7% | 81,675 | +358.3% | 0.19% | -17.5% |
| Q2 2020 | $320,000 | +1.3% | 17,820 | -14.3% | 0.23% | +188.9% |
| Q1 2020 | $316,000 | +17.0% | 20,800 | +52.1% | 0.08% | +478.6% |
| Q4 2019 | $270,000 | -61.4% | 13,674 | -66.4% | 0.01% | -62.2% |
| Q3 2019 | $700,000 | +293.3% | 40,674 | +303.8% | 0.04% | +311.1% |
| Q2 2019 | $178,000 | – | 10,074 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |